Meet Ottava, J&J’s surgical robot leading the healthcare giant into a lucrative new market
Johnson & Johnson is diving head-first into the deep end of the competitive robotic surgery market. The payoff…
Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push
Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…
FDA approves Gilead HIV pill Bixlenvo designed to simplify treatment
Gilead Bixlenvo drug Courtesy: Gilead The Food and Drug Administration approved a once-daily HIV pill from Gilead that…
HHS plans new FDA leadership roles for technology, drugs
The logo for the Food and Drug Administration is seen ahead of a news conference at the Health…
Why vaccination rates are falling in the U.S.
A Medical Assistant gives a measles, mumps and rubella, vaccination to a young person at the pediatric office…
Lilly sues six firms over alleged illegal sales of obesity drug retatrutide
Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…
CVS Health (CVS) earnings Q2 2026
CVS Health on Wednesday blew past second-quarter earnings and revenue estimates and raised its 2026 guidance, as its…
AstraZeneca and Bristol Myers Squibb mull $400 billion deal: Report
A smart acquisition strategy has made Bristol-Meyers, which has bought seven companies since October 2007, a big player…
New Medicaid work rules could leave rare disease patients uninsured
CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our journalism to elevate stories…
Novo Nordisk shares fall after heart medicine trial results
Shares of Novo Nordisk fell as much as 10% on Friday after the drugmaker said a late-stage heart…
Eli Lilly will file for approval of retatrutide obesity drug in 2027
The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…
Trump’s generic drug tariffs: What it means for patients, drugmakers and prices
President Donald Trump‘s proposed tariffs on imported generic medicines have raised fresh questions about whether low-cost drugmakers can…